General Information

All
  • All
  • Ongoing
  • Completed
Jul 21 @ 9:58 pm

NEAT

This trial will evaluate the effects of EryDex in patients with A-T.

more
Jul 21 @ 9:58 pm

Cerebrospinal Fluid Biomarker Study

Among the 204 identified CSF proteins, 13 showed significant changes in A-T patients versus control samples.

more
Jul 21 @ 9:58 pm

OxiDative Stress Clinical Trial

Two laboratory markers of oxidative stress improved when participants took both alpha-lipoic acid and nicotinamide.

more
Jul 21 @ 9:58 pm

L-Dopa Treatment Trial

No overall consistent improvement in neurologic function was observed on L-Dopa.

more
Jul 21 @ 9:58 pm

Global A-T Family Data Platform

The Platform is a patient-driven effort through which data about people with A-T are shared with researchers.

more
Jul 21 @ 9:58 pm

Pulmonary Function Study

This study seeks to establish the natural history of pulmonary function decline in the A-T population.

more
Jul 21 @ 9:58 pm

Nicotinamide Riboside (Niagen) Proof-of-concept Study

This trial in the Netherlands looked at the effects of nicotinamide ribose as a potential treatment for people with A-T.

more
Jul 21 @ 9:58 pm

PET Scan/FMRI Study

Participants with A-T demonstrated lower brain activity or metabolism in the cerebellum as compared to control participants.

more
Jul 21 @ 9:58 pm

Baclofen Study

At the dose tested, Baclofen did not have a significant effect on tremor, eye movement or balance deficits.

more
Jul 21 @ 9:58 pm

Dexamethasone Trial

This open label study was performed to assess the safety and tolerability of the EryDex System in people with A-T.

more
Jul 21 @ 9:58 pm

Betamethasone Trials

These trials studied whether a low dose betamethasone would reduce neurological symptoms associated with A-T.

more
Jul 21 @ 9:58 pm

Effect of Amantadine on Movement Disorder in A-T

This trial was performed to see if amantadine sulphate improves ataxia or other movement disorders associated with A-T.

more